United States medical device registration timeline
Source-linked clocksFood and Drug Administration (FDA) review clocks and end-to-end planning ranges, using the 3-class with pathways (I, II, III) classification system.
| Class / pathway | Review clock | Planning total | With prior approval | Provenance |
|---|---|---|---|---|
| 510(k)(Premarket Notification) FDA MDUFA decision goal: 90 FDA days, excluding days on hold for an Additional Information request | 90 days | 6-12 months | 6-8 months | Verified |
| De Novo(De Novo Classification) For novel devices without a legally marketed predicate | 150 days | 8-15 months | — | Verified |
| PMA(Premarket Approval) The statutory PMA review period is 180 days after filing (21 CFR 814.40(a)) | 180 days | 4-8 years | 4-6 years | Verified |
Planning steps and estimates; these are not regulator deadlines.
United States Medical Device Registration Process
Step-by-step FDA registration process. Total estimated timeline: 6-12 months.
Step 1: Device Classification
2-4 weeksDetermine FDA device class (I, II, or III) and identify predicate device for 510(k) submissions.
Step 2: Pre-Submission Meeting
2-3 monthsOptional Q-Sub meeting with FDA to discuss testing strategy and submission requirements.
Step 3: Testing & Documentation
3-6 monthsComplete biocompatibility, EMC, performance testing. Prepare technical file and 510(k) summary.
Step 4: 510(k) Submission
1 daySubmit 510(k) application to FDA via eCopy or eSTAR. Pay user fee (currently $22,381 for small business).
Step 5: FDA Review
90-180 daysFDA conducts substantive review. Average 160-176 calendar days. May issue Additional Information requests.
Step 6: 510(k) Clearance
1 dayFDA issues clearance letter (SE = Substantially Equivalent). Device can be marketed in the USA.
Priority review for innovative devices addressing unmet needs
Eligibility: Life-threatening condition, Irreversibly debilitating disease, Breakthrough technology
FDA meeting to align requirements before submission
Eligibility: All device classes, Recommended for complex devices
- US Agent (for foreign manufacturers)
- Establishment Registration
- Device Listing
- QSR/21 CFR 820 compliance
- eSTAR submission (mandatory Oct 2025)
MDSAP: Substitutes routine FDA inspections
Reviewed 2026-08-25. End-to-end totals remain planning estimates.